Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Regen BioPharma (RGBP) Prepaid Assets (2016 - 2025)

Regen BioPharma (RGBP) has disclosed Prepaid Assets for 11 consecutive years, with $200.0 as the latest value for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 99.61% to $200.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $200.0, a 99.61% decrease, with the full-year FY2025 number at $200.0, down 96.0% from a year prior.
  • Prepaid Assets was $200.0 for Q4 2025 at Regen BioPharma, roughly flat from $200.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $51250.0 in Q4 2024 to a low of $4.0 in Q1 2021.
  • A 5-year average of $14286.0 and a median of $5000.0 in 2022 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: surged 864450.0% in 2022, then crashed 99.61% in 2025.
  • Regen BioPharma's Prepaid Assets stood at $41288.0 in 2021, then tumbled by 87.89% to $5000.0 in 2022, then changed by 0.0% to $5000.0 in 2023, then soared by 925.0% to $51250.0 in 2024, then plummeted by 99.61% to $200.0 in 2025.
  • Per Business Quant, the three most recent readings for RGBP's Prepaid Assets are $200.0 (Q4 2025), $200.0 (Q3 2025), and $200.0 (Q2 2025).